Biopsy Devices Market Key Players Analysis- Argon Medical Devices, Inc., B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corporation.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopsy Devices Market- (By Product Type (Needle Biopsy Devices (Guidance Systems, Biopsy Consoles, Site Markers, Biopsy Guns (Automated Systems, Semi-Automated Systems), Needles), Skin Biopsy Devices (Punch Biopsy Instruments, Shave Biopsy Instruments), Consumables (Forceps, Trocars, Trays, Other Consumables), By Biopsy Type (Tissue Biopsy (Needle Biopsy, Surgical Biopsy, Skin Biopsy), Liquid Biopsy), By Anatomy (Breast, Lung, Bone, Liver, Uterus/Cervix, Abdomen, Prostate, Cardiac, Skin, Others), By Disease Type (Cancer, Infections, Autoimmune Disorders, Non-Cancerous Indications, Others), By Guidance Technique (Growth-Share Analysis, Ultrasound-Guided Biopsy, X-Ray-Guided Biopsy, MRI-Guided Biopsy, CT-Guided Biopsy)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Biopsy Devices Market is valued at US$ 6.03 Bn in 2022, and it is expected to reach US$ 20.04 Bn by 2031, with a CAGR of 14.39% during the forecast period of 2023-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2228

A biopsy is a medical procedure used to extract tissue samples for diagnostic purposes, particularly in the detection of cancer and other medical conditions. When cancer is suspected, biopsies are performed to collect tissue for further evaluation. Various biopsy techniques are utilized for cancer detection, including skin biopsy, vacuum-assisted biopsy, incision and excision biopsy, fine needle aspiration, core needle biopsy, and shave biopsy. The global rise in the incidence of various cancer types has significantly driven the demand for advanced diagnostic and treatment solutions. This increase in cancer cases has also raised awareness of the available diagnostic and screening methods.

The growing prevalence of cancers such as breast, prostate, and lung cancer, combined with rapid technological advancements in diagnostic tools, is expected to further fuel the demand for biopsy devices during the forecast period. Innovations such as 3D optical biopsies, MRI-targeted biopsies, and ultrasound-guided biopsies are improving the accuracy and efficiency of cancer diagnosis. Additionally, the increasing emphasis on the early detection of chronic diseases is driving demand for advanced biopsy techniques, including stereotactic-guided biopsy systems. The broad range of applications for biopsy devices is projected to contribute to substantial market growth in the coming years.

List of Prominent Players in the Biopsy Devices Market:
• Argon Medical Devices, Inc.
• B. Braun SE
• Becton
• Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Group Incorporated
• Conmed Corporation
• FUJIFILM Holdings Corporation
• GE Healthcare
• Inrad, Inc.
• Medtronic plc
• Olympus Corporation
• Siemens Healthineers AG
• Stryker Corporation
• Zamar Care
• Changzhou Jiuhong Medical Instrument Co., Ltd.
• Kindly (KDL) Meditech
• Ningbo Xinwell Medical Technology Co., LTD.
• Shenzhen Manners Technology Co., Ltd.
• Zhejiang Soudon Medical Technology Co., Ltd
• Agilent Technologies, Inc.
• BGI Group
• Biocept, Inc.
• Bio-Rad Laboratories, Inc.
• Dxcover Limited
• Elypta Limited
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• Micronoma
• QIAGEN
• Revvity, Inc.
• Sysmex Corporation
• Thermo Fisher Scientific Inc

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics
Drivers:
The biopsy device market is experiencing significant growth driven by several dynamic factors, including advancements in healthcare technology, regulatory developments, and the rising prevalence of chronic diseases. The global incidence of cancer has notably increased in recent years. According to GLOBOCAN projections, the number of cancer cases is expected to rise to 19.3 million by 2025, up from 19.3 million in 2020. Cancer remains the second leading cause of death in the United States, accounting for approximately one in four deaths. The American Cancer Society projected over 1.68 million new cancer cases (excluding carcinoma in situ) to be diagnosed in 2017, with an estimated 600,920 cancer-related deaths in the same year-equivalent to approximately 1,650 deaths per day. This surge in cancer incidence is driving the demand for biopsy devices.

Challenges:
One of the primary challenges faced by the biopsy device market is the high cost of biopsy instruments, which hinders broader adoption. Additionally, clinical challenges related to core needle biopsies, along with growing concerns regarding breast cancer screening procedures, are anticipated to affect market growth over the forecast period. Although biopsy techniques provide radiologists and surgeons with a means to assess abnormalities at specific sites, the invasive nature of these procedures, which involves making incisions to extract tissue samples, increases the risk of post-procedural infections. This heightened risk of infection could serve as a limiting factor for market expansion.

Regional Trends:
North America is expected to maintain a significant share of the biopsy device market in terms of revenue, with a strong compound annual growth rate (CAGR) projected for the near future. This growth is attributed to the region's robust healthcare infrastructure, the availability of highly skilled medical professionals, and the presence of key industry stakeholders. The Asia-Pacific region is also anticipated to witness substantial growth during the forecast period, driven by its large population base, rising disposable incomes, and growing awareness of disease screening. Furthermore, the increasing elderly population in the region, which is more susceptible to cancer, is expected to further propel market expansion.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2228

Recent Developments:
• In Sept 2023, A revolutionary collaboration has been declared between Roche France, Foundation Medicine, and the Institute Gustave Roussy to provide cancer patients in France with in-house liquid biopsy genomic testing. By transferring FoundationOne®Liquid CDx technology to the Institute Gustave Roussy, Roche France and Foundation Medicine have the potential to provide liquid biopsy testing for comprehensive genomic profiling (CGP) in all patients in France diagnosed with advanced cancer.
• In August 2022, Mammotome announced the release of the Mammotome DualCoreTM biopsy system, the company's first twin-stage core biopsy tool. This novel core biopsy device adds to the Mammotome ultrasound-guided breast biopsy portfolio, which already includes the Mammotome® Elite Tetherless Vacuum-Assisted Biopsy Device (tetherless VABB) and the Mammotome RevolveTM Dual Vacuum-Assisted Breast Biopsy System (tethered VABB).

Segmentation of Biopsy Devices Market-
By Product Type-
• Needle Biopsy Devices
o Guidance Systems
o Biopsy Consoles
o Site Markers
o Biopsy Guns
 Automated Systems
 Semi-Automated Systems
o Needles
• Skin Biopsy Devices
o Punch Biopsy Instruments
o Shave Biopsy Instruments
• Consumables
o Forceps
o Trocars
o Trays
o Other Consumables
By Biopsy Type
• Tissue Biopsy
o Needle Biopsy
o Surgical Biopsy
o Skin Biopsy
• Liquid Biopsy
By Anatomy-
• Breast
• Lung
• Bone
• Liver
• Uterus/Cervix
• Abdomen
• Prostate
• Cardiac
• Skin
• Others
By Disease Type-
• Cancer
• Infections
• Autoimmune Disorders
• Non-Cancerous Indications
• Others
By Guidance Technique -
• Growth-Share Analysis
• Ultrasound-Guided Biopsy
• X-Ray-Guided Biopsy
• MRI-Guided Biopsy
• CT-Guided Biopsy
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/biopsy-devices-market/2228

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.